BRIX1 and urothelial neoplasm: In the first set of TMA consisting of 129 cases of urothelial neoplasms and corresponding 72 non-neoplastic normal-appearing urothelial tissues, BXDC2 was positive in 65 (90%) of non-neoplastic and 99 (77%) of neoplastic specimens (Table 1).